Renal Clearance
The rate at which the kidneys remove a drug from the blood through filtration and excretion in urine. Smaller peptides and peptide fragments are efficiently filtered by the kidneys. PEGylation and albumin binding increase molecular size to reduce renal clearance and extend peptide drug half-lives.
Technical Context
The kidneys filter blood through approximately 1 million glomeruli, each with a molecular weight cutoff of approximately 60-70 kDa. Peptides below this threshold are freely filtered unless bound to larger carriers. Unbound peptide fragments are extensively filtered and reabsorbed/degraded by proximal tubular cells. Strategies to reduce renal clearance: PEGylation (adds 5-40 kDa mass), albumin binding (albumin ~67 kDa is not filtered + FcRn recycling extends its t1/2 to ~19 days), and Fc fusion (IgG Fc ~25 kDa per chain + FcRn recycling). Renal impairment can reduce peptide clearance and increase drug exposure, potentially requiring dose adjustment — this is assessed in dedicated renal impairment pharmacokinetic studies.